Placebo to MK-6194, MK-6194
MK-6194-007
Phase 2 small_molecule active
Quick answer
Placebo to MK-6194, MK-6194 for Non segmental vitiligo is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Non segmental vitiligo
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active